Analyst Price Target is $26.69
▲ +123.37% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Health Catalyst in the last 3 months. The average price target is $26.69, with a high forecast of $48.00 and a low forecast of $16.00. The average price target represents a 123.37% upside from the last price of $11.95.
Current Consensus is
The current consensus among 12 contributing investment analysts is to buy stock in Health Catalyst. This Buy consensus rating has held steady for over two years.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.